Allison Whelan examines how state restrictions on pharmaceuticals approved by the U.S. Food and Drug Administration contribute to disparities in health-care access. She contends that “health-care federalism in the United States . . . although at times beneficial, too frequently exacerbates health disparities.” Read more here.
